Initiation and promotion in radiation-induced myeloid leukemia - PubMed (original) (raw)
Affiliations
- PMID: 1625487
Initiation and promotion in radiation-induced myeloid leukemia
N Haran-Ghera et al. Leukemia. 1992 Jul.
Abstract
Acute myelomonocytic leukemia develops in 10-30% of irradiated (300 rad) SJL/J mice, after a lag period of around one year. Additional treatment with dexamethasone shortly after irradiation increased leukemia incidence up to 50%. Experiments were conducted in order to demonstrate the existence of preleukemic cells in irradiated mice and to explore the possible role of dexamethasone, cyclophosphamide, and different hemopoietic growth factors on their promotion to overt leukemia. Transplantation of bone marrow cells from mice exposed to 300 rad plus dexamethasone into appropriate recipients, performed 4-5 months after leukemogenic treatment, resulted in acute myeloid leukemia (AML) development of donor origin in 70% of the recipients. Transfer of fractionated preleukemic bone marrow showed that the highest AML incidence developed in the recipients of fractions enriched in early hemopoietic precursors. The promoting effect of dexamethasone on preleukemic cells was confirmed by demonstrating its similar coleukemogenic effect whether administered within several hours or 130 days after radiation. Treatment with cyclophosphamide shortly after radiation could not replace the dexamethasone effect but was found to be complementary to the coleukemogenic effect of dexamethasone. Early administration of hemopoietic growth factors (starting 14 days after radiation and dexamethasone) showed that colony-stimulating factor (CSF) 1 increased the AML incidence (75%) and reduced its latency. Treatment with recombinant granulocyte-CSF (rG-CSF) had a reduced effect and recombinant granulocyte-macrophage CSF (rGM-CSF) had no promoting effect. However, administration of different factors several months after the leukemogenic treatment revealed that rGM-CSF increased AML incidence (75%) and shortened its latency, whereas rG-CSF and CSF-1 had no effect. In contrast, the late administration of recombinant interleukin 6 reduced AML incidence significantly (23%). The present results indicate that murine radiation induced AML is a multiphase process involving radiation induced preleukemia that can be promoted by different treatments.
Similar articles
- Multiphase process involved in radiation induced murine AML.
Haran-Ghera N, Resnitzky P, Krautghamer R, Tartakovsky B. Haran-Ghera N, et al. Leukemia. 1992;6 Suppl 3:123S-125S. Leukemia. 1992. PMID: 1602807 - Deletion of chromosome 2 is an early event in the development of radiation-induced myeloid leukemia in SJL/J mice.
Trakhtenbrot L, Krauthgamer R, Resnitzky P, Haran-Ghera N. Trakhtenbrot L, et al. Leukemia. 1988 Aug;2(8):545-50. Leukemia. 1988. PMID: 3166080 - Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG. Drexler HG. Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
Cited by
- Revisiting the health effects of psychological stress-its influence on susceptibility to ionizing radiation: a mini-review.
Wang B, Katsube T, Begum N, Nenoi M. Wang B, et al. J Radiat Res. 2016 Jul;57(4):325-35. doi: 10.1093/jrr/rrw035. Epub 2016 May 29. J Radiat Res. 2016. PMID: 27242342 Free PMC article. Review. - TNF-alpha regulates the effects of irradiation in the mouse bone marrow microenvironment.
Cachaço AS, Carvalho T, Santos AC, Igreja C, Fragoso R, Osório C, Ferreira M, Serpa J, Correia S, Pinto-do-O P, Dias S. Cachaço AS, et al. PLoS One. 2010 Feb 1;5(2):e8980. doi: 10.1371/journal.pone.0008980. PLoS One. 2010. PMID: 20126546 Free PMC article. - Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
Walter MJ, Park JS, Ries RE, Lau SK, McLellan M, Jaeger S, Wilson RK, Mardis ER, Ley TJ. Walter MJ, et al. Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12513-8. doi: 10.1073/pnas.0504247102. Epub 2005 Aug 19. Proc Natl Acad Sci U S A. 2005. PMID: 16113082 Free PMC article. - Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.
Walter MJ, Park JS, Lau SK, Li X, Lane AA, Nagarajan R, Shannon WD, Ley TJ. Walter MJ, et al. Mol Cell Biol. 2004 Dec;24(24):10882-93. doi: 10.1128/MCB.24.24.10882-10893.2004. Mol Cell Biol. 2004. PMID: 15572690 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous